Trade

with

GW Pharmaceuticals PLC
(NASDAQ: GWPH)
AdChoices
71.70
-1.34
-1.83%
After Hours :
71.70
0.00
0.00%

Open

76.70

Previous Close

73.04

Volume (Avg)

756.80k (589.59k)

Day's Range

71.60-77.28

52Wk Range

28.00-111.46

Market Cap.

1.34B

Dividend Rate ( Yield )

-

Beta

-

Shares Outstanding

19.71M

P/E Ratio (EPS)

-

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
Industry Drug Manufacturers – Major
Highlights
Analyst Recommendation: Hold
    • Revenue

    • 44.11M

    • Net Income

    • -7.35M

    • Market Cap.

    • 1.34B

    • Enterprise Value

    • -

    • Net Profit Margin %

    • -59.13

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • -

    • Forward P/E

    • -555.56

    • Price/Sales

    • 24.75

    • Price/Book Value

    • 5.65

    • Price/Cash flow

    • -71.43

      • EBITDA

      • -15.03M

      • Return on Capital %

      • -13.59

      • Return on Equity %

      • -17.99

      • Return on Assets %

      • -13.59

      • Book Value/Share

      • 20.89

      • Shares Outstanding

      • 19.71M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      10/21/2014
      Hold
        • 1 Year Price Target

        • 6.90

        • Credit Rating

        • -

        • Analysts

        • 1

        • EPS Estimate

        • -2.45

        • Cashflow Estimate

        • -

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 4.90

          • 0.89

          • Net Income

            YTD/YTD (last year)

          • -

          • 7.80

          • Net Income

            Q/Q (last year)

          • -

          • 4.50

          • Sales (Revenue)

            5-Year Annual Average

          • 18.31

          • 6.10

          • Net Income

            5-Year Annual Average

          • -

          • 3.73

          • Dividends

            5-Year Annual Average

          • -

          • 2.17

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 93.31

            • 69.92

            • Pre-Tax Margin

            • -71.61

            • 21.84

            • Net Profit Margin

            • -59.13

            • 18.37

            • Average Gross Margin

              5-Year Annual Average

            • 96.80

            • 71.90

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -1.20

            • 21.92

            • Average Net Profit Margin

              5-Year Annual Average

            • 4.30

            • 903.40B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • 0.01

              • 0.32

              • Current Ratio

              • 8.67

              • 1.92

              • Quick Ratio

              • 8.42

              • 1.31

              • Interest Coverage

              • -272.10

              • 17.64

              • Leverage Ratio

              • 1.24

              • 2.03

              • Book Value/Share

              • 12.88

              • 14.72

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • -39.22

                • 21.88

                • P/E Ratio 5-Year High

                • -64.20

                • 193.96

                • P/E Ratio 5-Year Low

                • -4.87

                • 87.26

                • Price/Sales Ratio

                • 23.15

                • 3.70

                • Price/Book Value

                • 5.28

                • 3.69

                • Price/Cash Flow Ratio

                • -71.43

                • 13.85

                • Key Metrics

                • Company

                • Industry

                  • Return on Equity %

                    (5-Year Average)

                  • -17.99

                    (24.60)

                  • 17.42

                    (18.66)

                  • Return on Assets %

                    (5-Year Average)

                  • -13.59

                    (5.00)

                  • 8.45

                    (8.77)

                  • Return on Capital %

                    (5-Year Average)

                  • -17.57

                    (24.40)

                  • 12.41

                    (13.18)

                  • Income/Employee

                  • -

                  • 90.07k

                  • Inventory Turnover

                  • 0.43

                  • 2.46

                  • Asset Turnover

                  • 0.23

                  • 0.46

                  Current Historical
                  Financials
                  • Income Statement
                  • Balance Sheet
                  • Cash Flow
                  Operating Income
                  -16.92M
                  Operating Margin
                  -38.36
                  Total Equity
                  -
                  Retained Earnings
                  -
                  Free Cashflow
                  -
                  Price/Cashflow
                  -71.43
                  Ownership

                  Institutional Ownership

                  42.33%

                  Top 10 Institutions

                  40.97%

                  Mutual Fund Ownership

                  25.71%

                  Float

                  -

                  5% / Insider Ownership

                  -

                  Corporate insiders or major stockholders reporting trading activity in the stock.

                  Top Mutual Fund Owners

                  Top Institutional Owners

                  Mutual Fund Name

                  Institution Name

                  • Mutual Fund Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • VA CollegeAmerica Small Cap World

                  •  

                    1,215,600

                  • 0.27

                  • 6.17

                  • Undrly Pru (M&G) Recovery Pen

                  •  

                    870,905

                  • 0.00

                  • 5.28

                  • Franklin Biotechnology Discovery

                  •  

                    320,903

                  • 348.82

                  • 2.16

                  • Federated Kaufmann Fund

                  •  

                    317,403

                  • 22.12

                  • 2.14

                  • Fidelity® Blue Chip Growth Fund

                  •  

                    265,666

                  • 0.00

                  • 1.35

                  • Janus Global Life Sciences Fund

                  •  

                    236,436

                  • 11.42

                  • 1.59

                  • Fidelity® OTC Portfolio

                  •  

                    193,527

                  • 0.00

                  • 0.98

                  • Wells Fargo Advantage Discovery Fund

                  •  

                    172,100

                  • 0.47

                  • 0.87

                  • T. Rowe Price International Discovery

                  •  

                    127,974

                  • 0.00

                  • 0.86

                  • Institution Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Capital Research Global Investors

                  •  

                    1,863,100

                  • +130.44%

                  • 12.56

                  • M&G INVESTMENT MANAGEMENT LTD

                  •  

                    870,905

                  • 0.00%

                  • 5.87

                  • Fidelity Management and Research Company

                  •  

                    756,162

                  • -5.18%

                  • 5.10

                  • Franklin Advisers, Inc.

                  •  

                    446,870

                  • -5.22%

                  • 3.01

                  • Federated Global Inv Mgmt Corp

                  •  

                    401,514

                  • +1,143.08%

                  • 2.71

                  • AllianceBernstein LP

                  •  

                    373,440

                  • +32.50%

                  • 2.52

                  • Chesapeake Partners Management Co Inc

                  •  

                    354,278

                  • +128.04%

                  • 2.39

                  • Farallon Capital Management, L.L.C.

                  •  

                    352,500

                  • -46.91%

                  • 2.38

                  • Janus Capital Management LLC

                  •  

                    344,932

                  • +29.80%

                  • 2.33

                  • VHCP Management, LLC

                  •  

                    311,853

                  • -51.60%

                  • 2.10

                  Company Profile

                  Sector

                  Healthcare

                  Industry

                  Drug Manufacturers – Major

                  Type

                  -

                  Style

                  Small Core

                  GW Pharmaceuticals PLC was founded in 1998 is a public limited company & was incorporated on 15th February, 2001 under the laws of England and Wales. It is engaged in the research, development and commercialization of a range of cann...moreabinoid prescription medicines to meet patient needs in a wide range of medical conditions. Its reportable segments are Sativex Commercial, Sativex Research and Development, and Pipeline Research and Development. The Sativex Commercial segment promotes Sativex through strategic collaborations with major pharmaceutical companies for the currently approved indication of spasticity due to multiple sclerosis. The Sativex Research and Development segment seeks to maximize the potential of Sativex through the development of new indications. The current focus for this segment i...mores the Phase III clinical development programme of Sativex for use in treatment of cancer pain. The Pipeline Research and Development segment seeks to develop cannabinoid medications other than Sativex across a range of therapeutic areas using the Group’s proprietary cannabinoid technology platform and partnerships with international scientists. The company has operations in the United Kingdom, Europe, United States, Canada and Asia. Trademark Epidiolex is registered in the United Kingdom and approved for publication in the United States. The Company is subject to regulation by federal, state and local authorities in addition to the FDA, including the Centers for Medicare and Medicaid Services, other divisions of the U.S. Department of Health and Human Services, the U.S. Department of Justice and individual U.S. Attorney offices within the Department of Justice, and state and local governments.lessless

                  Key People

                  Mr Justin David Gover

                  CEO/Director

                  Dr Geoffrey William Guy

                  Chairman of the Board/Director

                  Mr Adam George

                  CFO/Director/Secretary

                  Mr Thomas Gerard Lynch

                  Director

                  Dr Stephen Wright

                  Director/Other Corporate Officer

                  • GW Pharmaceuticals PLC

                  • Porton Down Science Park

                  • Salisbury, Wiltshire SP4 0JQ

                  • GBR.Map

                  • Phone: +44 1980557000

                  • Fax: +44 1980557111

                  • gwpharm.com

                  Incorporated

                  2001

                  Employees

                  194

                  Send Feedback

                  We appreciate your input!

                  • I'm having trouble signing into my Microsoft account

                  • I’m having problems with the services stripe (Mail, Facebook, etc.)

                  • There is an issue with my weather information

                  • I see an error in the content

                  • Other

                  Please give an overall site rating: